logo

BNTC

Benitec Biopharma·NASDAQ
--
--(--)
--
--(--)

BNTC fundamentals

Benitec Biopharma (BNTC) released its earnings on May 14, 2025: revenue was 0 (YoY --), met estimates; EPS was -0.24 (YoY +85.37%), beat estimates.
Revenue / YoY
0
--
EPS / YoY
-0.24
+85.37%
Report date
May 14, 2025

Earnings

EPS
Revenue

Revenue & Expenses

Key Indicators

Benitec Biopharma (BNTC) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

Benitec Biopharma (BNTC)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown

Balance Sheet

Benitec Biopharma (BNTC)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown

Cash Flow

Benitec Biopharma (BNTC)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown

Revenue Breakdown

Where does Benitec Biopharma (BNTC) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:

Dividend

Track Benitec Biopharma (BNTC) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield